|
|
|
|
Report No. : |
497762 |
|
Report Date : |
16.03.2018 |
IDENTIFICATION DETAILS
|
Name : |
ATUL LIMITED (w.e.f.31.07.1996) |
|
|
|
|
Formerly Known
As : |
ATUL PRODUCTS LIMITED |
|
|
|
|
Registered
Office : |
Atul House, G I Patel Marg, Ahmedabad - 380014, Gujarat |
|
Tel. No.: |
91-79-26461294/ 26463706 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
11.12.1975 |
|
|
|
|
Com. Reg. No.: |
04-002859 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 296.800 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
L99999GJ1975PLC002859 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0388028921 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Divulged |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCA2390M |
|
|
|
|
Legal Form : |
A Public Limited Liability Company. The Company’s Shares are Listed on
the Stock Exchanges. |
|
|
|
|
Line of Business
: |
Manufacturing and selling of Life Science Chemicals and Performance and Other Chemicals and cater to the needs of varied industries such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Flavour, Food, Footwear, Fragrance, Glass, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Polymer, Rubber, Soap and Detergent, Sports and Leisure, Textile, Tyre and Wind Energy across the world. (Registered activity) Line of business is updated as
per latest annual report 2017. |
|
|
|
|
No. of Employees
: |
2434 (Approximately) NOTE: As per annual report 2017 that there is decrease in the number of employees over past years and current number employees are 2434. |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A++ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
Maximum Credit Limit : |
USD 55000000 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Atul Limited is engaged in manufacturing and selling of chemical
products. It has one of the biggest integrated chemical complexes in Asia with
a well-diversified product portfolio of around 920 products and 460
formulations. The company was incorporated in the year 1975 and is based in
Ahmedabad, Gujarat. It is an established company having excellent track
record. Financial position of the company is sound and healthy Fundamentals of
the company are strong. The rating takes into consideration sound financial profile marked by
healthy net worth base along with low debt level and favourable gap between
trade payables and trade receivables. Share price are quoted high on stock exchange (Share price INR 2633
with Face value INR 10.) Trade relation are fair. Business is active. Payment are reported to
be regular and as per commitments. In view of robust financial position and established track record, the
company can be considered normal for business dealings at usual trade terms
and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low
Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High
Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long Term Rating = (AA+) |
|
Rating Explanation |
High degree of safety and very low credit risk. |
|
Date |
October 2017 |
|
Rating Agency Name |
CARE |
|
Rating |
Long Term Rating = (A1+) |
|
Rating Explanation |
High degree of safety and very low credit risk. |
|
Date |
October 2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial
Reconstruction) LISTING STATUS
Subject’s name is
not listed as a Sick Unit in the publicly available BIFR (Board for Industrial
& Financial Reconstruction) list as of 16.03.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED BY
|
Name : |
Mr. Tejal Patel |
|
Designation : |
Manager |
|
Contact No.: |
91-9824101096 |
|
Date : |
13.03.2018 |
Tel. No.: 91-79-26461294 / 26463706 / 26460520 – Continuously ringing
LOCATIONS
|
Registered Office : |
Atul House, G I Patel Marg, Ahmedabad-380014, Gujarat,
India |
|
Tel. No.: |
91-79-26461294/ 26463706/26460520 |
|
Fax no : |
91-79-26404111 |
|
Mobile No.: |
Not Available |
|
E-Mail : |
careers@atul.co.in (Careers) aromatics@atul.co.in (Aromatics) bulk_inters@atul.co.in (Bulk Chemicals and Intermediates) crop_care@atul.co.in (Crop Protection (Brands | Bulk Actives | Institutional Sales) floras@atul.co.in (Floras) pharma@atul.co.in (Pharmaceuticals and Intermediates) polymers@atul.co.in (Polymers Business (Performance Materials) support_polymers@atul.co.in (Polymers Business (Retail) contact@atul.co.in (Suppliers) atul_ahmedabad@atul.co.in (Shareholders) contact@atul.co.in (Analysts) |
|
Website : |
|
|
|
|
|
Head Office : |
Colours Division Post Atul, Valsad – 396020, |
|
Tel. No.: |
91-2632-230000/ 230320/ 233261- 5 |
|
Fax No.: |
91- 2632- 233639 |
|
E-Mail : |
|
|
|
|
|
Mumbai Office : |
310 B, Veer Savarkar Marg, Adjacent to Prabhadevi Telephone Exchange, Opposite India United Mills, Prabhadevi, Dadar (West), Mumbai-400028, Maharashtra, India |
|
Tel. No.: |
91-22-39876000 |
|
Fax No.: |
91-22-24376061/ 24386065 |
|
E-Mail : |
|
|
|
|
|
Factory 1 : |
297, GIDC Industrial Estate, Ankleshwar - 393002, Gujarat, India |
|
|
|
|
Factory 2 : |
Atul, District Valsad - 396020, Gujarat, India |
|
|
|
|
Factory 3 : |
MIDC, Tarapur, Thane - 401506, Maharashtra, India |
|
|
|
|
Factory 4 : |
GIDC, Kharod, District Bharuch - 394115, Gujarat, India |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Samvegbhai Arvindbhai Lalbhai |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Shalimar, Shahibaug, Ahmedabad- 380004, Gujarat, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
21.01.2000 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00009278 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Sunilbhai Siddharthbhai Lalbhai |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Chairman and Managing Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Lalbhai Cottage, 13 Byramji Gamadia Marg, Mumbai-400026, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.07.2014 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00045590 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Hasmukh Shantilal Shah |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
10, Ishavashyam, Sevasi - Mahapura Road, Mahapura, Vododara- 391101, Gujarat, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
01.10.1934 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Mr. H S Shah is
a Director of the Company since October 21, 1992. Mr. Shah held several
senior and top positions in the Government of India and other academic |
research, commercial and social organisations. Mr. Shah holds
MA degree in Sociology from Gujarat University and has passed Indian
Administrative Service examination conducted by Union Public Service
Commission. Companies: Chairman,
Gujarat Industrial Investment Corporation Chairman and
Managing Director, Indian Petrochemicals Corporation Limited Vice Chairman,
GE Capital (India) Limited Academic |
Research: Chairman,
Darshak Itihas Nidhi Chairman,
Gujarat Ecology Society Chairman,
Gujarat Industrial Research and Development Agency Chairman,
National Institute of Design Founder
Chairman, Gujarat Institute of Desert Ecology Member, Board of
Governors of IIT, Mumbai President, Charutar
Arogya Mandal (Medical College and Hospital) Social: Chairman,
Gujarat Rural Institute for Socio Economic Reconstruction Vadodara Chairman,
Kachnar Trust Founder
President and Member, Heritage Trust Founder Trustee,
Indian Trust for Rural Heritage and Development Life Trustee,
BAIF Development Research Foundation Government: Chairman,
Gujarat Ecology Commission Joint Director,
Bureau of Public Enterprises, Government of India Joint Secretary
to the Prime Minister, Government of India Member, Central
Pollution Control Board Secretary, Posts
and Telegraph Board of India Others: Chairman, Vikram
A Sarabhai Community Science Centre Life Trustee and
Member, Gujarat Nature Conservation Society Trustee, Shram Mandir |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
02.11.1992 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00152195 |
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Satguru Sharan Baijal |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
B-4, Sector-30, Noida-201303, Uttar Pradesh, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
06.09.1929 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Dr. S S Baijal
is a Director of the Company since June 13, 1984. Dr. Baijal was a
Lecturer in Organic Chemistry, Lucknow University. He was a Whole-time
Director and CEO of Atic Industries Limited, Managing Director of IEL Limited
and Chairman and CEO of ICI companies in India. Dr. Baijal holds PhD degree in Chemistry from the University of
Allahabad. |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
13.06.1984 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00027961 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Bansidhar Sunderlal Mehta |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
5th Floor, Maheshwari Mansion, 34-Napean Sea Road, Mumbai-400006, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
16.04.1992 |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
19.09.1935 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Mr. B S Mehta is
a Director of the Company since April 16, 1992. Mr. Mehta is a Practicing
Chartered Accountant and is a Chief Mentor of B S Mehta and Co. He is a past
President of The Institute of Chartered Accountants of India. He was involved
in educational activities at the graduate and post graduate levels in the
University of Mumbai. Mr. Mehta holds
B Com (Hons) degree from the University of Mumbai and is a Fellow Member of
The Institute of Chartered Accountants of India. |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00035019 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Susim Mukul Datta |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
104b, Bakhtavar, Lower Colaba Road, Colaba, Mumbai-400005, Mumbai, 400005, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
01.07.1936 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Mr. S M Datta is
a Director of the Company since October 28, 2002. Mr. Datta is the
Chairman of Administrative Staff College of India. He is also associated with
various other renowned institutes. Mr. Datta was
the Chairman of Hindustan Unilever Limited as well as of all Unilever Group
companies in India and Nepal from 1990 to 1996. Mr. Datta is a
Chartered Engineer; Honorary Fellow - All India Management Association,
Fellow - Indian Institute of Chemical Engineers, Member - Society of Chemical
Industry (London) and Fellow - The Institution of Engineers (India). Mr. Datta holds
a post graduate degree in Science and Technology from the University of
Calcutta. |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
28.10.2002 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00032812 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Rajendra Ambalal Shah |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Panorama, 2nd Floor, 203, Walkeshwar Road, Mumbai-400006, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
07.07.1931 |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
26.07.2013 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00009851 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Vedanthachari Srinivasa Rangan |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
C-1003, 10th Floor, Ashok Towers, Dr S S Rao Road, Parel, Mumbai-400012, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
13.02.1960 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Mr. V S Rangan
is a Director of the Company since July 19, 2010. Mr. Rangan is an
Executive Director of Housing Development Finance Corporation Limited. Mr. Rangan is an
Associate of The Institute of Chartered Accountants of India and The
Institute of Cost and Works Accountants of India. |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
19.07.2010 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00030248 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Mukund Manohar Chitale |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
4/46, Vishnuprasad Society, Shahaji Raje Marg, Vile Parle (East), Mumbai-400057, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
16.11.1949 |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
04.08.2015 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00101004 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Baldev Raj Arora |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
6B Saker Apartments, Pochkhanawalla Road, Worli, Mumbai-400030, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
03.06.1944 |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
04.08.2015 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00194168 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Ms. Shubhalakshmi Aamod Panse |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Sno.130/132, Roseland Ph-II Pim. Saudagar, RH No. B/3, Pune- 411027, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
28.01.1954 |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
04.08.2015 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02599310 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Gopikannan Rengachari Thirukonda |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Whole-time Director and CFO |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Flat No.113,11th Floor, Buliding 1,Wing - B, Kalpa - Taru Aura, LBS Marg, Ghatkopar (W), Mumbai-400086, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
17.10.2014 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00048645 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Bharathy Narayanan Mohanan |
||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Whole-time Director and President - U&S |
||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
H-6, Down Colony, Post : Atul, Valsad-396020, Gujarat, India |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/ Age : |
26.05.1950 |
||||||||||||||||||||||||||||||||||||||||||||
|
Brief Resume : |
Mr. B N Mohanan
is a Whole-time Director of the Company since January 01, 2009. He joined the
Company in 1992. Mr. Mohanan has over
4 decades of professional experience in various capacities. Currently, he is
the President, Infrastructure Unit and also the Occupier. His
responsibilities include safety, health, environment, utilities and
engineering procurement. Mr. Mohanan holds BSc (Engg Hon) degree from the University of
Calicut. |
||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.04.2014 |
||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00198716 |
||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship
:
|
|||||||||||||||||||||||||||||||||||||||||||||
Note:
KEY EXECUTIVES
|
Name : |
Mr. Tejal Patel |
|
Designation : |
Manager |
|
|
|
|
Name : |
Mr. Lalit Prafullachand Patni |
|
Designation : |
Company Secretary |
|
Address : |
3 Suruchi Colony, Post Atul, Valsad-396020, Gujarat, India |
|
Date of Appointment : |
17.10.2014 |
|
DIN No.: |
ABHPP8893Q |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on December 2017
|
Category
of shareholder |
No.
of fully paid up equity shares held |
Shareholding
as a % of total no. of shares |
|
|
(A) Promoter & Promoter Group |
13239801 |
44.64 |
|
|
(B) Public |
16421932 |
55.36 |
|
|
Grand
Total |
29661733 |
100.00 |
|

Statement showing shareholding pattern of the Promoter
and Promoter Group
|
Category of
shareholder |
No.
of fully paid up equity shares held |
Shareholding
as a % of total no. of shares |
|
|
A1) Indian |
0.00 |
|
|
|
Individuals/Hindu
undivided Family |
880781 |
2.97 |
|
|
Samvegbhai Arvindbhai Lalbhai |
202377 |
0.68 |
|
|
Samvegbhai Arvindbhai |
114943 |
0.39 |
|
|
Hansaben Niranjanbhai Lalbhai |
97374 |
0.33 |
|
|
Sunil Siddharth Lalbhai |
91772 |
0.31 |
|
|
Saumya Samvegbhai Lalbhai |
82695 |
0.28 |
|
|
Vimla S Lalbhai |
65982 |
0.22 |
|
|
Swati S Lalbhai |
63500 |
0.21 |
|
|
Taral S Lalbhai |
50022 |
0.17 |
|
|
Anamikaben Samveghbhai Lalbhai |
47199 |
0.16 |
|
|
Sunil Siddharth |
31544 |
0.11 |
|
|
Astha Lalbhai |
20500 |
0.07 |
|
|
Nishtha Sunilbhai Lalbhai |
5500 |
0.02 |
|
|
Sanjaybhai Shrenikbhai Lalbhai Trustee of
Arvindbhai Lalbhai Family Trust |
3653 |
0.01 |
|
|
Sunil Lalbhai Employees Trust |
2000 |
0.01 |
|
|
Rajivbhai Chinubhai Lalbhai |
1225 |
0.00 |
|
|
Sheth Narottambhai Lalbhai |
495 |
0.00 |
|
|
Any Other
(specify) |
12359020 |
41.67 |
|
|
Aagam Holdings Private Limited |
6650000 |
22.42 |
|
|
Aeon Investments Private Limited |
2060817 |
6.95 |
|
|
Adhigam Investments Pvt Ltd |
1008301 |
3.40 |
|
|
Aayojan Resources Private Ltd |
602000 |
2.03 |
|
|
Shalva Investments Private Limited |
500000 |
1.69 |
|
|
Akshita Holdings Private Limited |
459784 |
1.55 |
|
|
Adhinami Investments Private Limited |
452350 |
1.53 |
|
|
Anusandhan Investments Limited |
235000 |
0.79 |
|
|
Ashini Investments Pvt Ltd |
200000 |
0.67 |
|
|
Aahvan Agencies Limited |
178943 |
0.60 |
|
|
Anshuman Holdings Private Limited |
11825 |
0.04 |
|
|
Sub Total A1 |
13239801 |
44.64 |
|
|
A2) Foreign |
0.00 |
|
|
|
A=A1+A2 |
13239801 |
44.64 |
|
Statement showing shareholding pattern of the Public
shareholder
|
Category &
Name of the Shareholders |
No.
of fully paid up equity shares held |
Shareholding
% calculated as per SCRR, 1957 As a % of (A+B+C2) |
|
|
B1) Institutions |
0 |
0.00 |
|
|
Mutual Funds/ |
6480651 |
21.85 |
|
|
Kotak Emerging Equity Scheme |
322269 |
1.09 |
|
|
DSP Blackrock Funds |
1243115 |
4.19 |
|
|
Reliance Capital Trustee Co Ltd |
610037 |
2.06 |
|
|
Franklin India Smaller Companies Fund |
390642 |
1.32 |
|
|
SBI Magnum Global Fund |
330000 |
1.11 |
|
|
HDFC Trustee Company Ltd |
884980 |
2.98 |
|
|
Canara Robeco Mutual Fund |
319066 |
1.08 |
|
|
Alternate
Investment Funds |
14150 |
0.05 |
|
|
Foreign
Portfolio Investors |
1391606 |
4.69 |
|
|
Financial Institutions/
Banks |
241440 |
0.81 |
|
|
Sub Total B1 |
8127847 |
27.40 |
|
|
B2) Central
Government/ State Government(s)/ President of India |
0 |
0.00 |
|
|
Central
Government/ State Government(s)/ President of India |
183080 |
0.62 |
|
|
Sub Total B2 |
183080 |
0.62 |
|
|
B3)
Non-Institutions |
0 |
0.00 |
|
|
Individual share
capital upto INR 0.200 Million |
4114623 |
13.87 |
|
|
Individual share
capital in excess of INR 0.200 Million |
2214817 |
7.47 |
|
|
Shivani Tejas Trivedi |
584739 |
1.97 |
|
|
Tejas Bhalchandra Trivedi |
591250 |
1.99 |
|
|
Any Other
(specify) |
1781565 |
6.01 |
|
|
Trusts |
509 |
0.00 |
|
|
HUF |
242689 |
0.82 |
|
|
NRI – Non- Repat |
80956 |
0.27 |
|
|
NRI – Repat |
93004 |
0.31 |
|
|
Clearing Members |
103817 |
0.35 |
|
|
Bodies Corporate |
1023389 |
3.45 |
|
|
Associated person |
162325 |
0.55 |
|
|
Associated Companies |
74876 |
0.25 |
|
|
Sub Total B3 |
8111005 |
27.35 |
|
|
B=B1+B2+B3 |
16421932 |
55.36 |
|
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and selling of Life Science Chemicals and Performance and Other Chemicals and cater to the needs of varied industries such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Flavour, Food, Footwear, Fragrance, Glass, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Polymer, Rubber, Soap and Detergent, Sports and Leisure, Textile, Tyre and Wind Energy across the world. (Registered activity) Line of business is updated as
per latest annual report 2017. |
||||||||||||
|
|
|
||||||||||||
|
Products : |
|
||||||||||||
|
|
|
||||||||||||
|
Brand Names : |
Not Divulged |
||||||||||||
|
|
|
||||||||||||
|
Agencies Held : |
Not Divulged |
||||||||||||
|
|
|
||||||||||||
|
Exports : |
Not Divulged |
||||||||||||
|
|
|
||||||||||||
|
Imports : |
Not Divulged |
||||||||||||
|
|
|
||||||||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Customers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
2434 (Approximately) NOTE: As per annual report 2017 that there is decrease in the number of employees over past years and current number employees are 2434. |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Deloitte Haskins and Sells LLP Chartered Accountants |
|
Address : |
Indiabulls Finance Centre, Tower 3, 27th 32nd
Floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai – 400013, Maharashtra,
India |
|
Tel. No.: |
91-22-61854000 |
|
Fax No.: |
91-22-61854001 |
|
|
|
|
Auditors : |
|
|
Name : |
Dalal and Shah LLP Chartered Accountants |
|
Address : |
252, Veer Savarkar Marg, Shivaji Park, Dadar (West), Mumbai – 400028, Maharashtra, India |
|
Tel No.: |
91-22-66691500 |
|
Fax No.: |
91-22-66547804 / 07 |
|
|
|
|
Cost Auditors |
|
|
Name : |
R. Nanabhoy and Company Cost Accountants |
|
|
|
|
Secretarial
Auditor: |
Ashish C Doshi |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Subsidiary
companies: |
|
|
|
|
|
Joint venture
company : |
|
|
|
|
|
Entity over which
control exercised by Key : |
|
|
|
|
|
Entities over which
Key Management Personnel or their close family members have significant influence
: |
|
|
|
|
|
Post-employment
benefit plan of Atul Limited |
Other Related Parties 4
|
1. Associate company upto November 30, 2016 | 2 Investments held through subsidiary companies | 3 Under liquidation | 4 Refer Note 27.6 for information on transaction with Post - employment benefit Plans mentioned above.
CAPITAL STRUCTURE
After 28.07.2017
Authorised Capital : INR 1600.000
Million
Issued Subscribed and paid Capital : INR 296.617 Million
As on 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
80000000 |
Equity Shares |
INR10/- each |
INR 800.000 Million |
|
80000000 |
Cumulative Redeemable Preference Shares |
INR10/- each |
INR 800.000 Million |
|
|
|
|
INR 1600.000
Million |
Issued Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
29691780 |
Equity Shares |
INR10/- each |
INR 296.917
Million |
Subscribed Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
29661733 |
Equity Shares |
INR10/- each |
INR 296.600
Million |
|
29991 |
Add: Forfeited shares |
INR 10/- each |
INR 0.200
Million |
|
|
|
Total |
INR 296.800 Million |
a) Rights,
preferences and restrictions:
The Company has one class
of shares referred to as Equity shares having a par value of INR 10.
i) Equity shares:
In the event of liquidation of the Company, the holders of Equity shares will be entitled to receive any of the remaining assets of the Company, after distribution of all preferential amounts and Preference shares. The distribution will be in proportion to the number of Equity shares held by the Shareholders. Each holder of Equity shares is entitled to one vote per share.
ii) Dividend:
The Company declares and pays dividend in Indian rupees. The dividend proposed by the Board is subject to the approval of the Shareholders in the ensuing Annual General Meeting.
b) Shares reserved
for allotment at a later date:
56 Equity shares are held in abeyance due to disputes at the time of earlier rights issues.
c) Details of
Shareholders holding more than 5% of Equity shares:
|
|
31.03.2017 |
|
|
Name of the
Shareholder |
Holding % |
Number of shares |
|
Aagam Holdings Private Limited |
22.41% |
66,50,000 |
|
Aura Securities Private Limited |
6.79% |
20,14,383 |
|
Aeon Investments Private Limited |
-- |
-- |
LISTING DETAILS:
|
BSE : 500027 NSE : ATUL |
|
|
Stock Exchange
Place : |
National Stock Exchange of India Limited |
|
Listed Date : |
--- |
|
|
|
|
ISIN |
INE100A01010 |
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES
OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
296.800 |
296.800 |
296.800 |
|
(b) Reserves & Surplus |
18911.400 |
12212.100 |
9861.000 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
19208.200 |
12508.900 |
10157.800 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
214.700 |
540.800 |
|
(b) Deferred tax liabilities
(Net) |
997.500 |
668.800 |
444.100 |
|
(c) Other long term
liabilities |
214.400 |
245.000 |
201.300 |
|
(d) long-term provisions |
200.400 |
172.300 |
158.600 |
|
Total
Non-current Liabilities (3) |
1412.300 |
1300.800 |
1344.800 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
1340.000 |
2473.900 |
1641.400 |
|
(b) Trade payables |
3290.600 |
2916.100 |
2626.300 |
|
(c) Other current liabilities |
870.100 |
1215.200 |
1422.200 |
|
(d) Short-term provisions |
76.200 |
427.000 |
425.600 |
|
Total
Current Liabilities (4) |
5576.900 |
7032.200 |
6115.500 |
|
|
|
|
|
|
TOTAL |
26197.400 |
20841.900 |
17618.100 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
9284.800 |
8827.800 |
5783.400 |
|
(ii) Intangible Assets |
0.200 |
0.000 |
0.000 |
|
(iii) Capital work-in-progress |
369.900 |
0.000 |
0.000 |
|
(iv) Intangible assets under
development |
32.200 |
0.000 |
0.000 |
|
(b) Non-current Investments |
5307.800 |
1445.600 |
1488.200 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
70.100 |
421.900 |
448.200 |
|
(e) Other Non-current assets |
792.800 |
570.400 |
541.300 |
|
Total
Non-Current Assets |
15857.800 |
11265.700 |
8261.100 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
3678.900 |
3741.800 |
3496.500 |
|
(c) Trade receivables |
5070.600 |
4201.200 |
4391.900 |
|
(d) Cash and cash equivalents |
72.100 |
51.800 |
62.900 |
|
(e) Short-term loans and
advances |
51.800 |
1265.000 |
1155.900 |
|
(f) Other current assets |
1466.200 |
316.400 |
249.800 |
|
Total
Current Assets |
10339.600 |
9576.200 |
9357.000 |
|
|
|
|
|
|
TOTAL |
26197.400 |
20841.900 |
17618.100 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
28482.700 |
24072.200 |
25556.500 |
|
|
Other Income |
424.600 |
974.200 |
153.100 |
|
|
TOTAL
|
28907.300 |
25046.400 |
25709.600 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
13245.100 |
12340.500 |
13332.200 |
|
|
Purchases of Stock-in-Trade |
180.400 |
196.800 |
282.200 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
178.800 |
(280.200) |
161.200 |
|
|
Excise duty |
1537.400 |
NA |
NA |
|
|
Employees benefits expense |
1732.300 |
1721.900 |
1538.500 |
|
|
Other expenses |
6906.700 |
6261.800 |
6485.200 |
|
|
TOTAL |
23780.700 |
20240.800 |
21799.300 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX, DEPRECIATION
AND AMORTISATION |
5126.600 |
4805.600 |
3910.300 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
210.200 |
258.400 |
236.400 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
4916.400 |
4547.200 |
3673.900 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
911.200 |
616.900 |
552.800 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
4005.200 |
3930.300 |
3121.100 |
|
|
|
|
|
|
|
Less |
TAX |
1152.200 |
1249.700 |
946.900 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
2853.000 |
2680.600 |
2174.200 |
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
11451.000 |
NA |
NA |
|
|
|
|
|
|
|
Add |
Transfer
from OCI on disposal of FVOCI equity instruments |
7.300 |
NA |
NA |
|
|
|
|
|
|
|
Add |
Remeasurement
gain | (loss) on defined benefit plans |
16.200 |
NA |
NA |
|
|
|
|
|
|
|
Less |
Dividend
on Equity shares for the year {2015-16: INR 10 per share, (2014-15:INR 8.50
per share)} |
296.600 |
NA |
NA |
|
|
|
|
|
|
|
Less |
Dividend
distribution tax on dividend |
60.500 |
NA |
NA |
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
Transfer to General Reserve |
NA |
0.000 |
0.000 |
|
|
Dividend |
NA |
300.000 |
250.000 |
|
|
Tax on Dividend |
NA |
20.000 |
50.000 |
|
|
Total
|
NA |
320.000 |
300.000 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S |
14311.300 |
2360.600 |
1874.200 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
13324.900 |
11480.300 |
11634.100 |
|
|
TOTAL
EARNINGS |
13324.900 |
11480.300 |
11634.100 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
NA |
3510.500 |
3710.500 |
|
|
Components and Stores parts |
NA |
67.900 |
159.100 |
|
|
Capital Goods |
NA |
156.700 |
58.300 |
|
|
TOTAL
IMPORTS |
NA |
3735.100 |
3927.900 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
96.18 |
90.37 |
73.3 |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
212.300 |
346.000 |
627.100 |
|
Cash generated from operations |
4413.900 |
4798.900 |
3886.900 |
|
Net cash flow from operating activity |
3639.200 |
3742.800 |
3169.600 |
QUARTERLY RESULTS
|
Particulars |
30.06.2017 |
30.09.2017 |
31.12.2017 |
|
Audited / Unaudited |
Unaudited |
Unaudited |
Unaudited |
|
|
1ST Quarter |
2nd Quarter |
3rd Quarter |
|
Net Sales |
6900.500 |
7872.500 |
8036.800 |
|
Total Expenditure |
6138.700 |
6623.900 |
6776.100 |
|
PBIDT (Excl OI) |
761.800 |
1248.600 |
1260.700 |
|
Other Income |
44.500 |
78.500 |
5.000 |
|
Operating Profit |
806.300 |
1327.100 |
1265.700 |
|
Interest |
26.200 |
26.600 |
18.500 |
|
Exceptional Items |
NA |
NA |
NA |
|
PBDT |
780.100 |
1300.500 |
1247.200 |
|
Depreciation |
259.600 |
261.100 |
259.100 |
|
Profit Before Tax |
520.500 |
1039.400 |
988.100 |
|
Tax |
176.200 |
338.700 |
328.200 |
|
Provisions and contingencies |
NA |
NA |
NA |
|
Profit After Tax |
344.300 |
700.700 |
659.900 |
|
Extraordinary Items |
NA |
NA |
NA |
|
Prior Period Expenses |
NA |
NA |
NA |
|
Other Adjustments |
NA |
NA |
NA |
|
Net Profit |
344.300 |
700.700 |
659.900 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
64.98 |
63.70 |
62.73 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
5.62 |
5.73 |
5.82 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
89.46 |
84.90 |
70.41 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
1.39 |
1.28 |
1.12 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
0.53 |
0.54 |
0.68 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.22 |
0.36 |
0.41 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability
/ Networth) |
0.08 |
0.24 |
0.28 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
0.29 |
0.56 |
0.60 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
0.50 |
0.71 |
0.57 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
24.39 |
18.60 |
16.54 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
10.02 |
11.14 |
8.51 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
10.89 |
12.86 |
12.34 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
14.85 |
21.43 |
21.40 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
1.85 |
1.36 |
1.53 |
|
|
|
|
|
|
Quick Ratio ((Current Assets
– Inventories) / Current Liabilities) |
1.19 |
0.83 |
0.96 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
0.73 |
0.60 |
0.58 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
5.23 |
10.22 |
9.47 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
1.85 |
1.36 |
1.53 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
STOCK PRICES
|
Face Value |
INR 10.00/- |
|
Market Value |
INR 2633.00/- |
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
296.800 |
296.800 |
296.800 |
|
Reserves & Surplus |
9861.000 |
12212.100 |
18911.400 |
|
Net
worth |
10157.800 |
12508.900 |
19208.200 |
|
|
|
|
|
|
Long Term borrowings |
540.800 |
214.700 |
0.000 |
|
Short Term borrowings |
1641.400 |
2473.900 |
1340.000 |
|
Current Maturities of Long term debt |
627.100 |
346.000 |
212.300 |
|
Total
borrowings |
2809.300 |
3034.600 |
1552.300 |
|
Debt/Equity
ratio |
0.277 |
0.243 |
0.081 |

YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
25556.500 |
24072.200 |
28482.700 |
|
|
|
(5.808) |
18.322 |

NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
25556.500 |
24072.200 |
28482.700 |
|
Profit |
2174.200 |
2680.600 |
2853.000 |
|
|
8.51% |
11.14% |
10.02% |

ABRIDGED
BALANCE SHEET – (CONSOLIDATED)
|
SOURCES
OF FUNDS |
|
31.03.2017 |
31.03.2016 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
296.800 |
296.800 |
|
(b) Reserves & Surplus |
|
19362.600 |
12450.400 |
|
(c) Non-controlling interests |
|
152.500 |
0.000 |
|
(d) Minority Interest |
|
0.000 |
56.200 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
19811.900 |
12803.400 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
3.800 |
244.500 |
|
(b) Deferred tax liabilities
(Net) |
|
1430.800 |
686.700 |
|
(c) Other long term
liabilities |
|
337.200 |
231.000 |
|
(d) long-term provisions |
|
201.500 |
174.500 |
|
Total
Non-current Liabilities (3) |
|
1973.300 |
1336.700 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
|
1445.900 |
2515.000 |
|
(b) Trade payables |
|
3374.900 |
3068.800 |
|
(c) Other current liabilities |
|
959.200 |
1253.800 |
|
(d) Short-term provisions |
|
96.000 |
440.300 |
|
Total
Current Liabilities (4) |
|
5876.000 |
7277.900 |
|
|
|
|
|
|
TOTAL |
|
27661.200 |
21418.000 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
|
9998.500 |
7496.500 |
|
(ii) Intangible Assets |
|
0.200 |
1.200 |
|
(iii) Capital work-in-progress |
|
589.900 |
1806.800 |
|
(iv) Intangible assets under
development |
|
32.200 |
0.000 |
|
(v) Goodwill |
|
237.500 |
0.000 |
|
(vi) Biological assets other than
bearer plants |
|
66.400 |
0.000 |
|
(vii) Investments accounted
for using the equity method |
|
100.000 |
0.000 |
|
(b) Non-current Investments |
|
4152.100 |
615.800 |
|
(c) Deferred tax assets (net) |
|
416.600 |
0.000 |
|
(d) Long-term Loan and Advances |
|
0.000 |
358.000 |
|
(e) Other Non-current assets |
|
770.100 |
573.500 |
|
Total
Non-Current Assets |
|
16363.500 |
10851.800 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
|
29.200 |
18.700 |
|
(b) Inventories |
|
4300.600 |
4348.400 |
|
(c) Trade receivables |
|
5189.600 |
4347.700 |
|
(d) Cash and cash equivalents |
|
283.000 |
228.300 |
|
(e) Short-term loans and
advances |
|
0.000 |
1304.400 |
|
(f) Other current assets |
|
1495.300 |
318.700 |
|
Total
Current Assets |
|
11297.700 |
10566.200 |
|
|
|
|
|
|
TOTAL |
|
27661.200 |
21418.000 |
PROFIT
& LOSS ACCOUNT– (CONSOLIDATED)
|
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
|
|
SALES |
|
|
|
|
|
Income |
|
29960.500 |
26014.400 |
|
|
Other Income |
|
525.500 |
307.100 |
|
|
TOTAL
|
|
30486.000 |
26321.500 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
|
13970.300 |
13288.000 |
|
|
Purchases of Stock-in-Trade |
|
274.000 |
211.100 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
|
110.500 |
(250.100) |
|
|
Excise duty |
|
1621.100 |
0.000 |
|
|
Employees benefits expense |
|
2001.400 |
1846.600 |
|
|
Share of net profit of associate company and joint venture
company accounted for using the equity method |
|
(46.700) |
0.000 |
|
|
Other expenses |
|
6888.700 |
6283.300 |
|
|
TOTAL |
|
24819.300 |
21378.900 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
|
5666.700 |
4942.600 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
251.700 |
275.700 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
|
5415.000 |
4666.900 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
|
954.400 |
657.900 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
|
4460.600 |
4009.000 |
|
|
|
|
|
|
|
Less |
TAX |
|
1227.100 |
1316.200 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
|
3233.500 |
2692.800 |
|
|
|
|
|
|
|
|
Other
Comprehensive Income |
|
|
|
|
|
a)
Items that will not be reclassified to profit and lo |
|
|
|
|
|
i) Fair value of equity instruments
through Other Comprehensive Income (FVOCI) |
|
773.600 |
NA |
|
|
ii) Remeasurement gain |
(loss) on defined benefit plans |
|
24.400 |
NA |
|
|
iii) Income tax related to
item no (ii) above |
|
(8.400) |
NA |
|
|
iv) Share of Other Comprehensive Income of associate
company and joint venture company accounted for using the equity |
|
0.200 |
NA |
|
|
b) Items that will be reclassified to profit and loss |
|
|
|
|
|
i) Effective portion of gain | (loss) on cash flow hedges |
|
(7.300) |
NA |
|
|
i) Income tax related to item no (i) above |
|
2.500 |
NA |
|
|
iii) Exchange differences on translation of foreign
operations |
|
44.500 |
NA |
|
|
Other
Comprehensive Income, net of tax |
|
829.100 |
NA |
|
|
|
|
|
|
|
|
Total
Comprehensive income for the year |
|
4062.600 |
NA |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
|
109.01 |
90.80 |
LEGAL
CASES
HIGH
COURT OF GUJARAT
|
|
CIVIL
APPLICATION (FOR ORDERS) No. 11985 of 2012 |
|
In FIRST APPEAL / 1951 /
2012 ( PENDING ) |
|
Status : PENDING |
( Converted from
: CAST/12157/2012 ) |
CCIN No :
001003201211985 |
|
|
|||||
|
|||||
|
|||||
|
S.NO. |
Name of the Petitioner |
Advocate On Record |
|
1 |
JENSON NICHOLSAN INDIA LTD |
MR ADIL R MIRZA for: Applicant(s) |
|
S.NO. |
Name of the Respondant |
Advocate On Record |
|
1 |
ATUL LIMITED |
|
|
|||
|
Presented On |
: 16/10/2012 |
Registered On |
: 17/10/2012 |
|
Bench Category |
: DIVISON BENCH |
District |
: VALSAD |
|
Case Originated From |
: THROUGH HIS/HER/THEIR ADVOCATE |
Listed |
: 4 times |
|
StageName |
: NOTICE & ADJOURNED MATTERS |
||
|
Classification |
·
DB - CIVIL APPLICATION - CODE OF
CIVIL PROCEDURE, 1908 - PRODUCTION OF ADDITIONAL EVIDENCE |
|
Act |
·
CIVIL PROCEDURE CODE, 1908 |
Office Details
|
|
S.
No. |
Filing
Date |
Document
Name |
Advocate
Name |
Court
Fee on Document |
Document
Details |
|
1 |
16/10/2012 |
APPLICATION |
MR ADIL R MIRZA ADVOCATE |
20 |
MR ADIL R
MIRZA:1-2 |
Linked
Matters
|
|||||
|
S.
No. |
CaseDetail |
Status
Name |
Disposal
Date |
Action/Coram |
|
1 |
FIRST APPEAL/1951/2012 |
PENDING |
- |
- ·
HONOURABLE MR.JUSTICE RAVI R.TRIPATHI ·
HONOURABLE MR.JUSTICE R.D.KOTHARI |
Court
Proceedings
|
||||
|
S. No. |
Notified Date |
CourtCode |
Board Sr. No. |
Stage |
Action |
Coram |
|
1 |
18/10/2012 |
1 |
11 |
OFFICE OBJECTION REMOVED |
NEXT DATE |
HONOURABLE MR.JUSTICE D.H.WAGHELA HONOURABLE MR.JUSTICE Z.K.SAIYED |
|
2 |
14/12/2012 |
1 |
6 |
NOTICE & ADJOURNED MATTERS |
NEXT DATE |
HONOURABLE MR.JUSTICE D.H.WAGHELA HONOURABLE MR.JUSTICE G.R.UDHWANI |
|
3 |
20/12/2012 |
1 |
22 |
FOR REGULAR ADMISSION |
NEXT DATE |
HONOURABLE MR.JUSTICE D.H.WAGHELA HONOURABLE MR.JUSTICE G.R.UDHWANI |
|
4 |
16/01/2013 |
1 |
18 |
NOTICE & ADJOURNED MATTERS |
NEXT DATE |
HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA HONOURABLE MR.JUSTICE J.B.PARDIWALA |
|
Available Orders |
||||||
|
S. No. |
Case Details |
Judge Name |
Order Date |
CAV |
Judgement |
Questions |
Transferred |
Download |
|
|
1 |
CIVIL APPLICATION/11985/2012 |
· HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA · HONOURABLE MR.JUSTICE J.B.PARDIWALA |
16/01/2013 |
N |
ORDER |
- |
Y |
||
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter involved
in |
Yes |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
BACKGROUND
Subject (the Company) is a public company limited by shares, incorporated and domiciled in India. Its registered office is located at Atul House, G I Patel Marg, Ahmedabad 380 014, Gujarat, India and principal place of business is located at Atul, Gujarat, India.
The Company is in the business of Life Science Chemicals and Performance and Other Chemicals and cater to the needs of varied industries such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Flavour, Food, Footwear, Fragrance, Glass, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Polymer, Rubber, Soap and Detergent, Sports and Leisure, Textile, Tyre and Wind Energy across the world.
PERFORMANCE
Sales increased by 10% from INR 24030.00 Million to INR 26390.000 Million mainly due to higher volumes (16%), partly offset by lower prices (6%). Sales in India increased by 3% from INR 11980.000 Million to INR 12390.000 Million. Sales outside India increased by 16% from INR 12050.000 Million to INR 14000.000 Million. The Earning per share increased from INR 92.53 to INR 96.18. While the operating profit before working capital changes increased by 1% from INR 4780.00 Million to INR 4850.000 Million, the net cash flow from operating activities decreased by 3% from INR 3750.000 Million to INR 364.000 Million. Sales of Life Science Chemicals (LSC) Segment increased by 10% from INR 7370.000 Million to INR 8070.000 Million, mainly because of higher sales in Sub-segments Crop Protection and Aromatics - I; its EBIT decreased by 19% from INR 1610.000 Million to INR 1300.000 Million. Sales of Performance and Other Chemicals (POC) Segment increased by 10% from INR 16660.000 Million to INR 18320.000 Million mainly because of higher sales in Sub-segments Aromatics - II and Polymers; its EBIT increased by 16% from INR 2490.000 Million stagnant at INR 2900.000 Million. More details are given in the Management Discussion and Analysis (MDA) Report. The borrowings of the Company decreased (including current maturities of long-term borrowings) by 49% from INR 3020.000 Million to INR 1550.000 Million despite payments towards capital expenditure of INR 176 Million.
Credit Analysis and Research Limited (CARE) maintained its credit rating at ‘AA+’ (double A plus) for long-term borrowings of the Company. Its rating for short-term borrowings and commercial paper remained at ‘A1+’ (A1 plus), the highest possible awarded by CARE.
The Company completed 3 expansion projects with an investment of INR 1170.000 Million which are expected to generate sales of INR 2200.000 Million at full capacity utilisation.
MANAGEMENT DISCUSSION
AND ANALYSIS
Product groups:
Herbicides, Insecticides, Fungicides, Others
The products falling under these product groups are used by customers belonging to Agriculture and Crop Protection Chemicals industries. The product groups comprise about 20 products and 40 formulations. 2,4-D, Indoxacarb and Isoprothiolane are some of the key products
During 2016-17, sales increased by 8% from INR 4220.000 Million to INR 4550.000 Million. Sales in India decreased by 8% from INR 1660.000 Million to INR 1530.000 Million; bulk sales in India increased by 20% from INR 69 Million to INR 830.000 Million whereas brand sales which are currently only in India decreased by 28% from INR 970.000 Million to INR 700.000 Million. Sales outside India increased by 18% from INR 2560.000 Million to INR 3020.000 Million and formed 66% of the total. Increase on account of volume was 22%. Sales increased mainly because of good demand for one of the key herbicides. The Company completed 2 projects and undertook 1 project for implementation.
The size of the world Agriculture industry is estimated at US$ 3.2 tn and is growing at about 3%. The size of the world Crop Protection Chemicals industry is estimated at US$ 56 bn and is growing at about 5%. There are about 60 major crop protection chemical companies which dominate the world marketplace. The main user industries, namely Agriculture and Crop Protection Chemicals, are growing well because of the need to feed a growing population under constraints of related resources. The Company will participate in this growth by i) building a strong sales and marketing organisation and broadening and deepening its presence in other countries, particularly in Africa and South America, ii) promoting its brand sales, iii) improving its manufacturing and working capital efficiencies, iv) generating and adding capacities and v) introducing new products and formulations.
Floods or famines may adversely affect the demand. Fluctuations in foreign exchange may impact sales realisations. Given that some of these chemicals can be toxic, it is essential to take due care in their manufacture and use. Registration costs are high in certain countries.
Product groups: API
intermediates, Active Pharmaceutical Ingredients, Others
The products falling under these product groups are used by customers belonging to Pharmaceutical industry for various therapeutic categories, such as anti-depressant, anti-diabetic, anti-infective, anti-retroviral and cardiovascular. The product groups comprise about 72 products. Carbonates, chloroformates, isocyanates and organic ureas are some of the key classes of products.
During 2016-17, sales increased by 10% from INR 3110.000 Million to INR 342 Million. Sales in India increased by 9% from INR 1630.000 Million to INR 1780.000 Million. Sales outside India increased by 11% from INR 1480.000 Million to INR 1640.000 Million and formed 48% of the total. Growth on account of volume was 9%. The Company completed 1 project and undertook 1 project for implementation. Atul Bioscience Limited (ABL), a 100% subsidiary company, focused on production of advanced API intermediates, increased its sales by 4% from INR 550.000 Million to INR 570.000 Million, primarily because of volume; it undertook 1 project for implementation.
The size of the world Pharmaceutical industry is estimated at US$ 1.75 tn, of which the conventional pharmaceutical segment is US$ 1.2 tn and is growing at about 8%. Of this, the size of the world API industry is estimated at US$ 150 bn and is growing at about 7%. There are about 20 major companies which dominate the world marketplace.
The main user industry, namely, Pharmaceutical, is growing well because of increasing awareness about diseases and health. The Company along with ABL will participate in this growth by i) widening its market reach, ii) increasing its manufacturing efficiencies, iii) generating and adding capacities, iv) introducing new products and v) forming long-term strategic alliances with other companies.
The prices of some products may come
down in a short time. Fluctuations in foreign exchange may impact sales
realisations.
Product groups:
Intermediates, Perfumery, Others
The products falling under these product groups are mainly used by customers belonging to Fragrance and Personal Care industries. The product groups comprise about 20 products. para Cresol, Sodium Sulphate and Sodium Sulphite are some of the key products.
During 2016-17, sales increased by 15% from INR 4690.000 Million to INR 5370.000 Million. Sales in India decreased by 12% from INR 1390.000 Million to INR 1230.000 Million. Sales outside India increased by 25% from INR 3300.000 Million to INR 4140.000 Million and formed 77% of the total. Growth on account of volume was 21%. The Company completed 2 projects and undertook 1 project for implementation.
The world market of para Cresol (a key product) is estimated at 63,000 mt and is growing at about 2%. Though earlier the product used to be manufactured in the UK and the USA, China and India are now major suppliers of the product. The size of the world Fragrance industry is estimated at US$ 11 bn and is growing at about 4% and the size of the world Personal Care industry is estimated at US$ 400 bn of which personal care ingredient segment is US$ 20 bn and is growing at about 4%.
The main user industries, namely, Fragrance and Personal Care, are growing well because of improving standard of living.
The Company will participate in this growth by i) broadening its market reach, ii) increasing its manufacturing efficiencies, iii) generating and adding capacities and iv) introducing new products.
BULK CHEMICALS AND
INTERMEDIATES
Product groups: Bulk
chemicals, Adhesion promoters, Others
The products falling under these product groups are used mainly for internal consumption and by customers belonging to Cosmetic, Dyestuff and Tyre industries. The product groups comprise about 21 products. Resorcinol, Resorcinol Formaldehyde Resins, Sulphur Trioxide, Chlorosulphonic Acid and Caustic Soda are some of the key products.
During 2016-17, (external) sales increased by 33% from INR 1040.000 Million to INR 1380.000 Million. Sales in India increased by 46% from INR 610.000 Million to INR 890.000 Million. Sales outside India increased by 14% from INR 430.000 Million to INR 490.000 Million and formed 36% of the total. Growth on account of volume was 34%. The Company completed 1 project and undertook 1 project for implementation.
The world market for Resorcinol (a key product) is estimated at US$ 320 mn and is growing at about 3%. The size of the world Tyre industry is estimated at US$ 220 bn and is growing at about 6.5%. The size of the world Chlor-alkali industry is estimated at US$ 70 bn and is growing at about 6%.
The Tyre industry is expected to grow further because of increasing population on the one hand and improving standard of living on the other. The captive consumption of bulk chemicals is expected to grow as the Company expands manufacturing capacities of its various products. The Company will participate in this growth by i) widening its market reach, ii) increasing its manufacturing efficiencies, iii) generating and adding capacities and iv)introducing downstream products. The demand and prices of bulk chemicals are cyclical in nature. Fluctuations in foreign exchange may impact sales realisations.
Colors
Product groups:
Textile dyes, Pigments, Paper dyes, Inks, Textile chemicals, Others
The products falling under these product groups are used by customers belonging to Textile, Paint and Coatings and Paper industries. The product groups comprise about 571 products. Green 1, P Red and Sulphur Black are some of the key products.
During 2016-17, sales increased by 3% from INR 3940.000 Million to INR 4070.000 Million. Sales in India increased by 2% from INR 2200.000 Million to INR 2240.000 Million. Sales outside India increased by 5% from INR 1740.000 Million to INR 1830.000 Million and formed 45% of the total. Growth on account of volume was 7%. The Company completed 2 projects. Rudolf Atul Chemicals Limited (RACL), a joint venture company formed in 2011-12, provides a complete range of textile chemicals in the Indian market; it increased its sales by 10% from INR 590.000 Million to INR 650.000 Million, primarily because of volume.
The size of the world Dyestuff industry is estimated at US$ 5.6 bn and is growing at about 3.5%. China is the largest manufacturer of dyes followed by India. The world market for high performance pigments is estimated at US$ 4.7 bn and is growing at about 3.8%.
The main user industries, namely, Paint and Coatings and Textile, will continue to grow because of increase in discretionary spending. The Company along with RACL will participate in this growth by i) broadening its market reach in new geographies, ii) increasing its manufacturing and working capital efficiencies and iii) introducing new dyes, pigments and products for non-textile applications.
Fluctuations in foreign exchange and availability of raw materials may impact sales realisations. Treatment costs are expected to remain high given that the manufacture of dyes and pigments generates significant pollutants.
Polymers
Product groups: Epoxy
Resins and Hardeners, Reactive Diluents, Sulphones, Rubber and Polyurethane
based Adhesives, Others
The products falling under these product groups are used by customers belonging to Aerospace, Automobile, Composites, Construction, Defence, Electrical and Electronics, Footwear, Paint and Coatings, Paper, Sports and Leisure and Wind Energy industries. The product groups comprise about 96 synthetic products and 300 formulations. B11, P62 and P101 are some of the key products.
During 2016-17, sales increased by 7% from INR 6990.000 Million to INR 7500.000 Million. Sales in India increased by 4% from INR 4450.000 Million to INR 4620.000 Million; bulk sales in India increased by 9% from INR 6120.000 Million to INR 6650.000 Million whereas retail sales decreased by 2% from INR 870.000 Million to INR 850.000 Million. Sales outside India increased by 13% from INR 2540.000 Million to INR 2880.000 Million and formed 38% of the total. Growth on account of volume was 14%. The Company completed 1 project and undertook 1 project for implementation.
The world market for epoxy resins and hardeners is estimated at US$ 6.3 bn and is growing at about 2% and Indian market is estimated at US$ 250 mn and is growing at about 6%. There are about 7 major companies which dominate the world marketplace. The world market for sulphones (hardener) is estimated at US$ 320 mn and is growing at about 4%.
The user industries, Construction, Defence, Electrical and Electronics, Paint and Coatings and Wind Energy are growing well, particularly in India. The Company will participate in this growth by i) widening its market reach, ii) increasing its manufacturing and working capital efficiencies, iii) generating and adding new capacities of epoxy resins and hardeners and iv) introducing new products and formulations.
Cheaper imports of epoxy resins and hardeners may keep the margins under pressure. Since the 2 main raw materials, namely Bisphenol-A and Epichlorohydrin, are imported, fluctuations in foreign exchange may impact margins.
UNSECURED LOAN
|
Unsecured Loan |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Short-term
borrowings |
|
|
|
Loan from banks including foreign banks |
518.700 |
530.700 |
|
Loan from Related Parties |
0.000 |
105.000 |
|
Buyers' credit |
0.000 |
69.100 |
|
Commercial papers |
739.500 |
1000.000 |
|
Deposit from the Directors |
0.100 |
0.100 |
|
Total |
1258.300 |
1704.900 |
|
SNo |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of Modification |
Date of
Satisfaction |
Amount |
Address |
|
1 |
A34455931 |
10090594 |
12/02/2008 |
25/03/2008 |
- |
781200000.0 |
Godrej Bhavan, 3rd FloorMurzban Road, FortMumbaiMH400001IN |
|
|
2 |
G40275000 |
80026120 |
12/02/2005 |
10/03/2017 |
- |
5300000000.0 |
Commercial Branch, Paramasiddhi Complex,Opp. V S Hospital, Ellisbridge, Ashram Road,AhmedabadGJ380006IN |
|
|
3 |
Z00119945 |
80026296 |
08/03/1999 |
- |
- |
150000000.0 |
CENTRE ONE, WORLD TRADE CENTRECUFFE PARADEMUMBAIMH400005IN |
|
|
4 |
G57653354 |
10409602 |
28/02/2013 |
16/03/2013 |
29/09/2017 |
527700000.0 |
Mid Corporate Group, Commercial Br., ParamsiddhiComplex, EllisbridgeAhmedabadGJ380006IN |
|
|
5 |
G03600137 |
10273656 |
28/01/2011 |
31/05/2012 |
03/05/2016 |
276000000.0 |
First Floor, Eros Corporate TowerNehru PlaceNew DelhiDL110019IN |
|
|
6 |
C78061108 |
10294426 |
27/06/2011 |
30/07/2011 |
28/01/2016 |
562500000.0 |
Maruti Suzuki Building, 3rd Floor, Plot No. 1Nelson Mandela Road, Vasant KunjNew DelhiDL110070IN |
|
|
7 |
B70965686 |
10084402 |
21/01/2008 |
08/05/2009 |
11/03/2013 |
195000000.0 |
Centre One Building, Floor 21,World Trade Centre, Cuffe Parade,MumbaiMH400005IN |
|
|
8 |
B70967799 |
80023284 |
03/03/2006 |
17/03/2007 |
11/03/2013 |
310000000.0 |
Centre One Building, Floor 21, World Trade CentreCuffe ParadeMumbaiMH400005IN |
|
|
9 |
B69445856 |
10046279 |
24/03/2007 |
25/03/2008 |
11/02/2013 |
225000000.0 |
51, G Floor, Mulla HouseHutatma Chowk, Fort,MumbaiMH400023IN |
|
|
10 |
B60041852 |
80033730 |
13/07/2001 |
- |
18/10/2012 |
865000000.0 |
CREDIT APPRAISAL CELL, COMMERCIAL BRANCH,"PARAMSIDDHI" COMPLEX, OPP. V.S. HOSPITAL,AHMEDABADGJ380006IN |
STATEMENT OF
STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST
DECEMBER 2017
|
|
|
Particulars |
quarter ended |
quarter ended |
Nine months ended |
|
|
|
|
31.12.2017 |
30.09.2017 |
31.12.2017 |
|
1 |
|
Income from
Operations |
|
|
|
|
|
|
Sales/Income from Operations (Gross) |
8036.800 |
7872.500 |
22809.800 |
|
|
|
b) Other Operating Income |
5.000 |
78.500 |
128.000 |
|
|
Total Income from
Operations (Net) |
8041.800 |
7951.000 |
22937.800 |
|
|
2 |
Expenses |
|
|
|
|
|
|
a) |
Cost of Materials consumed |
4113.700 |
3961.400 |
11817.800 |
|
|
b) |
Purchase of Stock-in-trade |
12.500 |
8.900 |
73.300 |
|
|
c) |
Changes in inventories of finished goods, work-in-progress and
stock-in-trade |
232.500 |
371.600 |
345.600 |
|
|
d) |
Excise Duty |
-- |
-- |
400.700 |
|
|
e) |
Power, Fuel and Water |
871.600 |
858.100 |
2503.100 |
|
|
f) |
Employee benefit expenses |
856.300 |
449.200 |
1334.300 |
|
|
g) |
Finance Costs |
18.500 |
26.600 |
71.300 |
|
|
h) |
Depreciation and amortization expense |
259.100 |
261.100 |
779.800 |
|
|
i) |
Other expenses |
1089.500 |
974.700 |
3063.900 |
|
|
Total Expenses |
7053.700 |
6911.600 |
20389.800 |
|
|
9 |
Profit /(Loss) from
ordinary activities before tax |
988.100 |
1039.400 |
2548.000 |
|
|
10 |
Tax Expense |
328.200 |
338.700 |
843.100 |
|
|
11 |
Net Profit /(Loss)
from ordinary activities after tax |
659.900 |
700.700 |
1704.900 |
|
|
|
Other Comprehensive
Income: |
|
|
|
|
|
a. |
Items that will not
be reclassified to profit and loss |
|
|
|
|
|
|
- Fair value of equity instruments through other Comprehensive Income |
764.900 |
(16.500) |
614.000 |
|
|
|
- Remeasurement of Defined benefit plans |
12.300 |
5.100 |
16.100 |
|
|
|
- Income tax related to item |
(4.300) |
(1.700) |
(5.600) |
|
|
b. |
Items that will be
reclassified to profit and loss |
|
|
|
|
|
|
- Effective portion of gain I |
3.300 |
(5.300) |
12.500 |
|
|
|
- Income tax related to item |
(1.100) |
1.800 |
(4.300) |
|
|
|
Other Comprehensive Income for the year, net of taxes |
775.100 |
(16.600) |
632.700 |
|
|
|
Total Other Comprehensive
Income for the period |
1435.000 |
684.100 |
2337.600 |
|
|
|
|
|
|
|
|
|
12 |
Paid up equity share capital (Eq. shares of INR 10/- each) |
296.600 |
296.600 |
296.600 |
|
|
13 |
Reserve excluding revaluation reserves |
|
|
|
|
|
14 |
|
Earnings per share (before/after extraordinary items) of Rs.10/- each |
|
|
|
|
|
|
Basic & Diluted |
22.25 |
23.62 |
57.48 |
SEGMENT WISE REVENUE,
RESULTS AND CAPITAL EMPLOYED FOR THE QUARTER ENDED AND NINE MONTHS ENDED 31ST
DECEMBER 2017
|
Particulars |
Quarter ended |
Quarter ended |
Nine months ended |
|
|
(Unaudited) |
(Unaudited) |
(Unaudited) |
|
1. Segment Revenue |
31.12.2017 |
30.09.2017 |
31.12.2017 |
|
Life Science Chemicals |
2625.400 |
2708.900 |
7820.700 |
|
Performance and Other Chemicals |
5921.000 |
5620.200 |
16379.300 |
|
Total Segment
Revenue |
8546.400 |
8329.100 |
24200.000 |
|
Inter Segment Sales |
509.600 |
456.600 |
1390.200 |
|
Sales from
Operations |
8036.800 |
7872.500 |
22809.800 |
|
|
|
|
|
|
2. Segment Results |
|
|
|
|
Life Science Chemicals |
293.000 |
329.900 |
834.300 |
|
Performance and Other Chemicals |
803.700 |
711.400 |
1881.300 |
|
Total |
1096.700 |
1041.300 |
2715.600 |
|
Less: i) Interest |
18.500 |
26.600 |
71.300 |
|
ii. Other-Un-allocable Expenditure net off |
90.100 |
(24.700) |
96.300 |
|
Total Profit /
(Loss) before Tax |
988.100 |
1039.400 |
2548.000 |
|
|
|
|
|
|
Segment Assets |
|
|
|
|
Life Science Chemicals |
6559.300 |
6685.700 |
6559.300 |
|
Performance and Other Chemicals |
14459.300 |
14173.500 |
14459.300 |
|
Unallocated |
6953.600 |
6084.100 |
6953.600 |
|
Total Segment
Assets |
27972.200 |
26943.300 |
27972.200 |
|
|
|
|
|
|
Segment Liabilities |
|
|
|
|
Life Science Chemicals |
1626.100 |
1674.600 |
1626.100 |
|
Performance and Other Chemicals |
3409.100 |
3162.400 |
3409.100 |
|
Unallocated |
1724.200 |
2328.500 |
1724.200 |
|
Total Segment
Liabilities |
6759.400 |
7165.500 |
6759.400 |
Note:
1. The above results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on January 18, 2018, and approved by the Board of Directors at its meeting held on January 19, 2018. The Statutory Auditors of the Company have carried out a limited review of the financial results for the quarter / nine months ended on December 31, 2017. Their limited review report does not have any qualification / modification.
2. The Company has reported Segment information as per Indian Accounting
Standard 108 on 'Operating Segment', as below.
3. Revenue from operations upto June 30, 2017 includes excise duty, which is
discontinued effective July 01, 2017 upon implementation of Goods and Services
Tax (GST) in India. In accordance with 'Ind AS 18, Revenue', GST is not
included in revenue from operations. In view of the aforesaid restructuring of
indirect taxes, revenue from operations for the quarter / nine months ended on
December 31, 2017 are not comparable with the previous periods.
CONTINGENT
LIABILITIES:
(INR in million)
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
|
Claims against the
Company not acknowledged as debts in respects of: |
|
|
|
I. Excise duty |
80.000 |
77.000 |
|
II. Income tax |
62.400 |
75.200 |
|
III. Sales tax |
6.700 |
6.700 |
|
IV. Custom duty |
1.800 |
1.800 |
|
V. Water charges |
872.700 |
896.500 |
|
VI. Others |
64.300 |
144.200 |
|
VII. In respect of a customer claim amounting to INR 323.500 Million, the Company, based on legal opinion, believes that the claim will not sustain. |
|
|
|
The above matters are currently being considered by the tax authorities | various forums and the Company expects the judgement will be in its favour and has therefore, not recognised the provision in relation to these claims. Future cash outflow in respect of above will be determined only on receipt of judgement | decision pending with tax authorities | various forums. The potential undiscounted amount of total payments for taxes that the Company may be required to make if there was an adverse decision related to these disputed demands of regulators as of the date reporting period ends are as stated above. |
|
|
FIXED ASSETS
Tangible
Assets
Intangible Assets
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or
was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.93 |
|
|
1 |
INR 90.72 |
|
Euro |
1 |
INR 80.32 |
INFORMATION DETAILS
|
Information
Gathered by : |
SWT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
SUJ |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
YES |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.